JMP Securities maintains $220 target on Digital Realty stock
JMP Securities reiterated its Market Outperform rating on Digital Realty Trust (NYSE:DLR) with a steady price target of $220.00. The firm's analysis highlights Digital Realty Trust's fourth-quarter 2024 performance,
Reddit price target raised at JMP Securities, would use pullback to buy shares
JMP Securities raised the firm’s price target on Reddit (RDDT) to $200 from $190 and keeps an Outperform rating on the shares. Reddit reported
Cloudflare, CyberArk see price targets raised at JMP ahead of earnings
JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry overview of cybersecurity stocks ahead of quarterly results.
JMP maintains Life360 stock with $55 target, cites growth
JMP Securities maintained its Market Outperform rating on Life360 stock (NASDAQ:LIF) with a consistent price target of $55.00, representing potential upside from the current price of $46.40. The firm's analysts highlighted the unique position of Life360 in the market,
Rezolute price target raised to $9 from $8 at JMP Securities
JMP Securities analyst Jason Butler raised the firm’s price target on Rezolute (RZLT) to $9 from $8 and keeps an Outperform rating on the
Exelixis stock holds firm with $41 target from JMP Securities
JMP Securities maintained a Market Outperform rating and a $41.00 price target for Exelixis (NASDAQ:EXEL) shares, aligning with the broader analyst consensus as five analysts have recently revised their earnings estimates upward.
JMP Securities lifts Rezolute stock target to $9, maintains rating
JMP Securities adjusted its financial outlook for Rezolute (NASDAQ:RZLT), increasing the price target to $9.00 from the previous $8.00, while keeping a Market Outperform rating on the stock. Currently trading at $4.
Enanta Pharmaceuticals’ (ENTA) Market Outperform Rating Reiterated at JMP Securities
JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has ...
JMP Securities Reaffirms Their Buy Rating on Angi (ANGI)
JMP Securities analyst Nicholas Jones CFA maintained a Buy rating on Angi (ANGI – Research Report) today and set a price target of $2.75. The ...
Yahoo Finance16d
JMP Securities Raises CyberArk Software Ltd. (CYBR) Price Target to $390 on Strong Identity Security Outlook
We recently compiled a list of the 12 AI News Investors Probably Missed. In this article, we are going to take a look at where CyberArk Software Ltd. (NASDAQ:CYBR) stands against the other AI stocks.
Esperion Therapeutics’ (ESPR) “Market Outperform” Rating Reiterated at JMP Securities
JMP Securities reissued their market outperform rating on shares of Esperion Therapeutics (NASDAQ:ESPR – Free Report) in a research report sent to investors on Tuesday morning,Benzinga reports. They ...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
Buy Cloudflare Or Sell? Analysts Vary Over Sales Acceleration And Business Momentum
Wall Street analysts rerated Cloudflare, Inc (NYSE:NET) after the company released its fourth-quarterly print Thursday.
Citizens JMP's Devin Ryan talks Coinbase results
Devin Ryan, Citizens JMP senior analyst, joins 'Closing Bell Overtime' to talk Coinbase earnings. What would Nike be without ...
OppFi stock extends slump as JMP downgrades to Market Perform on valuation
OppFi (OPFI) shares dipped 4.9% in Wednesday midafternoon trading, adding to the prior trading session's retreat, after JMP ...